Home › Myeloproliferative Neoplasms › Kansas › Overland Park
Myeloproliferative Neoplasms clinical trials in Overland Park, KS
3 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around Overland Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi away
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi away
Myeloproliferative Neoplasms trials in other cities
- Houston, TX16 studies
- New York City, NY15 studies
- Boston, MA14 studies
- Milwaukee, WI10 studies
- Miami, FL10 studies
- Durham, NC9 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Chicago, IL9 studies
- Portland, OR8 studies
- Cleveland, OH8 studies
- Atlanta, GA8 studies
Other studies in Overland Park
- Non-Small Cell Lung Cancer16 studies
- Acute Myeloid Leukemia11 studies
- Lung Cancer11 studies
- Breast Cancer10 studies
- Atrial Fibrillation8 studies
- Colorectal Cancer8 studies
- Obesity7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Melanoma6 studies
- Overweight6 studies
- Ovarian Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.